1. Home
  2. BVS vs EMBC Comparison

BVS vs EMBC Comparison

Compare BVS & EMBC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Bioventus Inc.

BVS

Bioventus Inc.

HOLD

Current Price

$10.50

Market Cap

617.1M

Sector

Health Care

ML Signal

HOLD

Logo Embecta Corp.

EMBC

Embecta Corp.

HOLD

Current Price

$9.59

Market Cap

524.1M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
BVS
EMBC
Founded
2011
1924
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Electromedical & Electrotherapeutic Apparatus
Medical/Dental Instruments
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
617.1M
524.1M
IPO Year
2016
2021

Fundamental Metrics

Financial Performance
Metric
BVS
EMBC
Price
$10.50
$9.59
Analyst Decision
Strong Buy
Buy
Analyst Count
3
2
Target Price
$14.00
$18.50
AVG Volume (30 Days)
440.5K
766.9K
Earning Date
05-05-2026
05-08-2026
Dividend Yield
N/A
6.24%
EPS Growth
163.46
20.90
EPS
0.33
0.74
Revenue
$568,087,000.00
N/A
Revenue This Year
$7.52
$1.17
Revenue Next Year
$7.06
N/A
P/E Ratio
$32.03
$12.97
Revenue Growth
N/A
N/A
52 Week Low
$5.81
$8.47
52 Week High
$10.58
$15.55

Technical Indicators

Market Signals
Indicator
BVS
EMBC
Relative Strength Index (RSI) 72.96 58.54
Support Level $8.43 $8.60
Resistance Level N/A $10.88
Average True Range (ATR) 0.36 0.35
MACD 0.14 0.14
Stochastic Oscillator 91.98 85.66

Price Performance

Historical Comparison
BVS
EMBC

About BVS Bioventus Inc.

Bioventus Inc is a medical device company focused on developing and commercializing products to relieve pain and address musculoskeletal conditions. The company operates through two reporting segments, U.S. and International, and its product portfolio is organized into three main business areas: Pain Treatments, Surgical Solutions, and Restorative Therapies, offering products such as hyaluronic acid injections for osteoarthritis, peripheral nerve stimulation devices, bone graft substitutes, and ultrasound-based fracture healing therapies.

About EMBC Embecta Corp.

Embecta Corp is a medical device company focused on providing solutions to improve the health and well-being of people living with diabetes. It has a broad portfolio of marketed products, including various pen needles, syringes, and safety devices, which are complemented by a proprietary digital application designed to assist people with managing their diabetes. The company predominantly sells products to wholesalers and distributors that sell to retail and institutional channels who in turn sell to patients or use the products to deliver insulin injections to patients. It also provides contract manufacturing services. Geographically, the company derives a majority of its revenue from the United States.

Share on Social Networks: